Found 8 matching trials
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers N/A This is a single-center, bidirectional (retrospective and prospective) regi...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE) PHASE2 This is a single arm phase II study to explore the 3y LRFS and safety for h...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer NA The goal of this clinical trial is to test the safety and efficacy of local...
Show More Location
Peking University Cancer Hospital & Institute
Learn More & Join Trial
Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal Cancers N/A Purpose:
The purpose of this study is to evaluate the safety and efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer N/A Aim: To investigate the safety and efficacy of organ preservation (OP) with...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment N/A This study is designed to test the efficacy of tailored operative or non-op...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity NA A phase II, single-center, non-profit, interventional study on patients aff...
Show More Location
Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment
Learn More & Join Trial
A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial) PHASE2 This study adopts a prospective randomized controlled design to evaluate th...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial